Osiris Therapeutics, Inc. To Present At UBS Warburg Global Life Sciences Conference

BALTIMORE--(BUSINESS WIRE)--Sept. 15, 2006--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today that C. Randal Mills, Ph.D., President and CEO, will be presenting at the UBS Global Life Sciences Conference in New York City on September 25, 2006. The presentation is scheduled for 1:00 PM (Eastern Time). A live web cast may be accessed through the Company's website at www.Osiris.com. The presentation will be archived on the Osiris website for a limited time, under the Investors tab, beginning approximately three hours after the presentation.